Gritstone Bio Inc (GRTS)

11.12 +0.28  +2.58% NASDAQ Nov 26, 16:00 USD
View Full Chart
Price Chart
View All GRTS News

News

View All Events

Events

Date Type Description
03/11/2022 Earnings Results Q4 2021 Earnings Results
11/03/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 Earnings Results Q2 2021 Earnings Results
06/18/2021 09:00 EST AGM 2021 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/11/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Gritstone Bio Inc is a United States-based biotechnology company. It is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.
  • URL: https://www.gritstonebio.com
  • Investor Relations URL: https://ir.gritstonebio.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 11, 2022
  • Last Earnings Release: Nov. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
CBTG Cabot Growth ETF 4.55%
BBC Virtus LifeSci Biotech Clinical Trls ETF 0.72%
BRSIX Bridgeway Ultra-Small Company Market 0.54%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.